Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Specific and potent RNAi in the nucleus of human cells.

Robb GB, Brown KM, Khurana J, Rana TM.

Nat Struct Mol Biol. 2005 Feb;12(2):133-7. Epub 2005 Jan 9.

PMID:
15643423
2.

[Great potential of small RNAs: RNA interference and microRNA].

Vázquez-Ortiz G, Piña-Sánchez P, Salcedo M.

Rev Invest Clin. 2006 Jul-Aug;58(4):335-49. Review. Spanish.

PMID:
17146945
3.

RNA interference (RNAi) in hematology.

Scherr M, Steinmann D, Eder M.

Ann Hematol. 2004 Jan;83(1):1-8. Epub 2003 Oct 22. Review.

PMID:
14574462
4.

Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.

Takahashi Y, Nishikawa M, Takakura Y.

Adv Drug Deliv Rev. 2009 Jul 25;61(9):760-6. doi: 10.1016/j.addr.2009.04.006. Epub 2009 Apr 20. Review.

PMID:
19386274
5.

RNA interference--significance and applications.

Stanisławska J, Olszewski WL.

Arch Immunol Ther Exp (Warsz). 2005 Jan-Feb;53(1):39-46. Review.

PMID:
15761375
6.

The potential of modulating small RNA activity in vivo.

van Mil A, Doevendans PA, Sluijter JP.

Mini Rev Med Chem. 2009 Feb;9(2):235-48. Review.

PMID:
19200028
7.

Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.

He S, Zhang D, Cheng F, Gong F, Guo Y.

Mol Biol Rep. 2009 Nov;36(8):2153-63. doi: 10.1007/s11033-008-9429-7. Epub 2009 Jan 1. Review.

PMID:
19117119
8.

miRNAs on the move: miRNA biogenesis and the RNAi machinery.

Murchison EP, Hannon GJ.

Curr Opin Cell Biol. 2004 Jun;16(3):223-9. Review.

PMID:
15145345
9.

Short interfering RNA (siRNA)-mediated RNA interference (RNAi) in human cells.

Caplen NJ, Mousses S.

Ann N Y Acad Sci. 2003 Dec;1002:56-62. Review.

PMID:
14751822
10.

RNAi in functional genomics.

Scherr M, Eder M.

Curr Opin Mol Ther. 2004 Apr;6(2):129-35. Review.

PMID:
15195923
11.

Small RNAs and non-small cell lung cancer.

Tong AW.

Curr Mol Med. 2006 May;6(3):339-49. Review.

PMID:
16712479
12.

[The application of RNAi to the medical genetics].

Wu D, Wu BY, Liang HY, Zhong N.

Beijing Da Xue Xue Bao. 2005 Feb 18;37(1):106-11. Review. Chinese.

13.

Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing.

Chakraborty C.

Curr Drug Targets. 2007 Mar;8(3):469-82. Review.

PMID:
17348839
14.

Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.

Aigner A.

J Biotechnol. 2006 Jun 25;124(1):12-25. Epub 2006 Jan 18. Review.

PMID:
16413079
15.

Gene silencing in human embryonic stem cells by RNA interference.

Rassouli FB, Matin MM.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1106-10. doi: 10.1016/j.bbrc.2009.10.038. Epub 2009 Oct 13. Review.

PMID:
19833094
16.

Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.

Akhtar S, Benter I.

Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):164-82. Epub 2007 Mar 21. Review.

PMID:
17481774
17.

Delivery strategies for siRNA-mediated gene silencing.

Gilmore IR, Fox SP, Hollins AJ, Akhtar S.

Curr Drug Deliv. 2006 Apr;3(2):147-5. Review.

PMID:
16611001
18.

Design of shRNAs for RNAi-A lesson from pre-miRNA processing: possible clinical applications.

Pekarik V.

Brain Res Bull. 2005 Dec 15;68(1-2):115-20. Epub 2005 Sep 9. Review.

PMID:
16325011
19.

The Argonautes.

Joshua-Tor L.

Cold Spring Harb Symp Quant Biol. 2006;71:67-72. Review.

PMID:
17381282
20.

RNA interference: from gene silencing to gene-specific therapeutics.

Leung RK, Whittaker PA.

Pharmacol Ther. 2005 Aug;107(2):222-39. Review.

PMID:
15908010

Supplemental Content

Support Center